[1]
H. Titou, “The Efficacy and Safety of Nemolizumab in Patients with Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”, Dermatol Pract Concept, vol. 15, no. 4, p. 5967, Oct. 2025, doi: 10.5826/dpc.1504a5967.